Skip to content

Evaluation of the Preliminary Application Effect of Hazard Analysis and Critical Control Points (HACCP) in the Prevention and Management of Breast Cancer-Related Lymphedema

Construction and preliminarily application of the quality control system of prevention and management of breast cancer-related lymphedema based on HACCP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101941
Enrollment
Unknown
Registered
2025-05-06
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer-related lymphedema

Interventions

Control group:usual care
Experimental group:Based on the intervention of the control group, the BCRL early prevention management quality control system based on HACCP that has been constructed and formed in this study was imp

Sponsors

Affiliated Cancer Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All patients were confirmed to have breast cancer by histopathological examination; 2. Age >= 18 years; 3. underwent axillary lymph node dissection 4. Capable of good communication; 5. Informed consent to participate in this study and able to cooperate with follow-up procedures.

Exclusion criteria

Exclusion criteria: 1. Presence of cognitive impairment or communication barriers in language or writing; 2. Upper limb disability; 3. Severe dysfunction of the heart, liver, or kidneys; 4. Patients who have already developed upper limb edema for any reason.

Design outcomes

Primary

MeasureTime frame
Incidence of lymphedema;Breast Cancer Lymphedema Prevention Knowledge;Team management capability of group members;Satisfaction score of patients and their families;

Countries

China

Contacts

Public ContactHuang Caiying; Zhou Ying

Guangzhou Medical University Fifth Affiliated Hospital

1379956356@qq.com+86 136 4086 3316

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026